During the past 12 months, NeoGenomics's average Revenue per Share Growth Rate was 10.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.90% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 5.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 11.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of NeoGenomics was 140.00% per year. The lowest was -56.80% per year. And the median was 15.20% per year.
Competitive Comparison of NeoGenomics's 3-Year Revenue Growth Rate
For the Diagnostics & Research subindustry, NeoGenomics's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NeoGenomics's 3-Year Revenue Growth Rate Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, NeoGenomics's 3-Year Revenue Growth Rate distribution charts can be found below:
* The bar in red indicates where NeoGenomics's 3-Year Revenue Growth Rate falls into.
This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.
NeoGenomics 3-Year Revenue Growth Rate Related Terms
Thank you for viewing the detailed overview of NeoGenomics's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NEO has been successfully added to your